Arcus Design Group is working on the implementation
of a new Pilot Plant for Morphotek, Inc. located in Lionville, PA. The project includes the demolition of three existing buildings and construction of a 60,000 SF building with interior equipment platform and interstitial catwalk system.
Site Improvements and complete Fit-out will accommodate Offices, Research & Development Laboratories, cGMP Cell Culture Core Area and Warehouse, as well as supporting Mechanical, Electrical and Plumbing Systems. The Owner intends to pursue Certification under LEED for New Construction, Version 2.2. Re:Vision Architecture has been retained to assist the design team for the LEED process
during design and execution of the project. This project follows completion of a previous 20,000 SF addition and interior renovation for the headquarters facility. Morphotek, Inc., a subsidiary of Eisai, Inc., is a Biopharmaceutical Company focused on the discovery and development of therapeutic monoclonal antibodies for the treatment of
cancer, inflammatory and infectious diseases.
|